Healthcare Industry News: Novation
News Release - December 11, 2009
MAQUET Cardiovascular Awarded Three-Year Contract From Novation for Cardiopulmonary Products Used in Cardiac Surgery
WAYNE, N.J., Dec. 11 -- (Healthcare Sales & Marketing Network) -- MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, announced today that it has signed a three-year contract with Novation, the industry's leading supply contracting company, to provide all of its cardiopulmonary (perfusion) products to the members of VHA Inc., University HealthSystem Consortium (UHC) and Provista. The agreement becomes effective on January 1, 2010, and runs through December 31, 2012. MAQUET Cardiovascular's cardiopulmonary products are used in on-pump cardiac surgery and include heart-lung machines, the QUADROX-i family of generators, the ROTAFLOW Centrifugal Pump, the MECC (Minimized Extracorporeal Circulation) System, the PLEGIOX Cardioplegia Heat Exchanger, standard or customized tubing packs and a full line of adult, pediatric and ECMO cannulae."This agreement represents an important milestone for MAQUET Cardiovascular as it is our first GPO contract for cardiopulmonary products in the United States and underscores the value of our products to surgeons and perfusionists," said Raoul Quintero, President of MAQUET Cardiovascular U.S. Sales LLC. "We are committed to supporting positive patient outcomes and are pleased that members will now have access to our full range of innovative perfusion products, as well as our surgical devices for beating heart cardiac surgery and our market-leading VASOVIEW Endoscopic Vessel Harvesting (EVH) Systems through two contracts we signed with Novation previously."
"Novation continues to provide members of VHA, UHC and Provista with the most advanced technology, best customer service and preferred pricing. We found that MAQUET Cardiovascular's cardiopulmonary product portfolio met the requirements of our rigorous contracting review process," said Scott Crandall, Senior Director, Contract Services Cardiology at Novation. "We are pleased that this is the third agreement we have signed this year with MAQUET Cardiovascular."
About Novation
Founded in 1998, Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances and nearly 15,000 members of Provista, LLC. Novation offers its customers contract development and management, supply chain data and measurement, and industry knowledge and advocacy. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 500 suppliers. VHA, UHC and Provista members used Novation contracts to purchased nearly $35.7 billion in 2008.
About MAQUET Cardiovascular
MAQUET Cardiovascular is a leader in providing innovative products for cardiac surgery, vascular intervention and cardiac support to hospitals and clinics and the cardiac surgeons, interventional cardiologists, perfusionists and other healthcare professionals who care for patients with cardiovascular disease. MAQUET Cardiovascular is focused on providing clinicians with future-oriented technology that fits into their daily practice and that improves the therapeutic management of patients. MAQUET Cardiovascular continues to invest in the development of innovative technologies and solutions that advance clinical practice, improve patient outcomes and enhance quality of life.
MAQUET Cardiovascular was formed in 2003 when MAQUET combined its existing Cardiopulmonary business with Jostra's equipment and consumables for open heart surgery and Siemens Life Support Systems that GETINGE acquired in 2003. In 2008, it added the Cardiac Surgery and Vascular Interventions businesses that GETINGE acquired from Boston Scientific and Guidant in 2008. In 2009, it added the cardiac assist businesses that GETINGE acquired from Datascope. MAQUET Cardiovascular provides healthcare professionals with products in four business units: Cardiopulmonary (perfusion products), Cardiac Surgery (clampless beating heart and endoscopic vessel harvesting), Vascular Interventions (vascular surgery products), and Cardiac Assist (intra-aortic balloon counterpulsation therapy).
About MAQUET
The MAQUET Group is the global market leader for Medical Systems, focusing on the Operating Room (OR) and Intensive Care Unit (ICU). The integrated products of MAQUET are specially designed to deliver optimal clinical treatment and therapy concepts within acute care hospitals. MAQUET provides innovative medical solutions from three divisions:
- Cardiovascular with products for cardiac assist (intra-aortic balloon counterpulsation therapy), coronary artery bypass surgery, aneurysm and vascular repair, peripheral interventions and extracorporeal circulation.
- Critical Care for intensive care ventilators and anesthesia machines.
- Surgical Workplaces for OR tables, lights and ceiling service units, prefabricated OR and ICU suites, as well as telemedicine for the OR integration.
MAQUET is a subsidiary of the publicly-listed Swedish GETINGE GROUP, a company with over $2.8 billion in revenues (2008 fiscal year) and 12,800 employees worldwide. In 2008 MAQUET itself generated pro-forma revenues (including the acquisition of Datascope Corp.) of over $1.4 billion. The company now has 5,000 employees in 35 international sales and service organizations, as well as a network of more than 200 sales representatives.
www.maquet.com
www.getingegroup.com
MAQUET - The Gold Standard.
Source: MAQUET Cardiovascular
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
